The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression.
By W. Katon, Michael Von Korff, E. Lin, Gregory E. Simon, Evette Ludman, J. Russo, Paul S. Ciechanowski, E. Walker, T. Bush. Archives of General Psychiatry, 2004
773 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Oncology
View Paper: https://www.semanticscholar.org/paper/e8e041a6dccefec6437e757997d5a1f9e791515a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Epidemiology
Citations in the corpus
- Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. (2006, background): “In the available effectiveness trials conducted in real clinical practice settings, even the addition of depression care specialists leads to modest remission rates (15% to 35%) (10, 13, 14).”
- The impact of comorbid chronic conditions on diabetes care. (2006, background): “Such clinically focused research has led to important insights, although one recent rigorous trial evaluating health system changes to improve care for comorbid depression found little impact on diabetesspecific outcomes (36).”
- Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association (2016, background): “Within the primary care setting, older adults with diabetes and comorbid depression are likely to benefit from a collaborative care intervention approach, which uses a nurse caremanager supervised by a primary care physician and psychiatrist (58,112,113).”
- Diabetes Distress but Not Clinical Depression or Depressive Symptoms Is Associated With Glycemic Control in Both Cross-Sectional and Longitudinal Analyses (2009, result): “Congruent with prior research, we find no evidence of a statistically significant relationship between MDD and glycemic control or between depressive symptoms and glycemic control (8,21).”